In the fall of 2017, APEX Ventures announced the closing of its first venture capital fund, APEX One. In the final closing, 16 million euros were made available for early stage deep tech investments. The new APEX Digital Health Fond was expected to gain 50 million euros in capital – and the threshold for the first closing has already been reached. As already with Apex One, Brandl & Talos, under the leadership of Roman Rericha and Markus Arzt, have successfully supported APEX in the corporate law structuring and the FMA regulatory approval procedure in Austria.
Smart Contracts are on the rise. But how does the blockchain-technology coexist with formal requirements of arbitration? Written by Raphael Toman & Florian Braunauer.
Whistleblowers risk their professional lives by revealing grievances and secret information. They are also often persecuted by the judiciary like criminals. But thanks to a new EU directive, reprisals and the like should be a thing of the past – in return, whistleblowers must adhere to certain rules of the game. Written by Christopher Schrank & Gregor Kristöfl.
This year´s topic: Private Capital – A Source for Economic Growth in Austria and the CEE. The AVCO ANNUAL CONFERENCE brings together investors, service providers and entrepreneurs. This year we will also invite market participants of the CEE Region. Join the conversation, get new insights and extend your network!
An event especially aimed at managing directors, board members and decision-makers of SMEs. The discussion will deal with concrete problems, examine possible solution approaches, and offer assistance and support to the attending companies.
The annual Compliance Solutions Day (25 September 2019) is taking place for the sixth time. This year's motto: Calculated Risk – Compliance in Uncertain Times. The full-day conference promises orientation for effective compliance management in precarious times. Christopher Schrank will provide information on the benefits of internal investigations coordinated with the public prosecutor's office.